Influenza vaccine effectiveness in elderly persons, 2015-2018

Duration: May 2015 - October 2018

Influenza viruses undergo frequent genetic and antigenic changes. Monitoring of vaccine effectiveness is important.

Research queation
What is the influenza vaccine effectiveness among elderly in Europe?

We estimatate the influenza vaccine effectiveness by using the 'test-negative case-control' method and the screening method with data from health registries and large electronic databases in Spain, Finland, Denmark, the Netherlands, Scotland and England.

Project partners
EpiConcept, France (projectleider); many health research institutes within Europe
Instituto De Salud Carlos IIII (ISCIII), Spain
Health Service Executive (HSE), Ireland
NHS National Services Scotland, United Kingdom
National Institute of Research-Development for Microbiology and Immunology "Cantacuzino", Romania
National Institute of Public Health - National Institute of Hygiene (NIZP-PZH), Poland
Instituto Nacional de Saúde Dr. Ricardo Jorge, Portugal
Instituto de Salud Pública y Laboral de Navarra, Spain
Royal College of General Practitioners (RCGP), United Kingdom
CIC St Eloi - Centre Hospitalier Universitaire de Montpellier, France
Centre Cochin-Pasteur de Vaccinologie, Assistance Publique-Hôpitaux de Paris, France
Public Health England, United Kingdom
Croatian National Institute of Public Health (CNIPH), Croatia
Stichting Nederlands Instituut voor Onderzoek van de Gezondheidszorg (NIVEL), The Netherlands
The University of Edinburgh (UEDIN), United Kingdom
National Institute for Health and Welfare (THL), Finland
Statens Serum Institut, Denmark
Robert Koch Institut, Germany
Office of the Chief Medical Officer (OCMO), Hungary
Istituto Superiore di Sanità, Italy
Institut de veille sanitaire (InVS), France
Université Pierre et Marie Curie (UPMC), France
Norwegian Institute of Public Health (NIPH), Norway
National Institute for Public Health and the Environment (RIVM), Netherlands

A report that contributes tot a sustainable platform of primary care practices, hospitals and laboratorium networks in Europe that share validated methods to evaluate post marketing vaccine performances.
Dit project wordt gesubsidieerd door
European Commission (EU)
EpiConcept, France (projectleider); many health research institutes within Europe